Analyst · Disc Medicine, Inc. (IRON) | Ratings, Price Targets & Consensus

Analyst Consensus

Buy13 analysts

Buy

Updated Jul 24, 2026

Total Analysts13

Strong Buy

1

Buy

10

Ratings

Updated Jul 24, 2026

Overall Rating

C+

DCF Score3.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$74.12

Median Target+43.74%

$106.54

Potential upside vs current price

DCF Value-96.89%

$2.31

Potential downside vs current price

Analyst Consensus

Buy13 analysts

Buy

Updated Jul 24, 2026

Total Analysts13

Strong Buy

1

Buy

10

Ratings

Updated Jul 24, 2026

Overall Rating

C+

DCF Score3.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$74.12

Median Target+43.74%

$106.54

Potential upside vs current price

DCF Value-96.89%

$2.31

Potential downside vs current price